As of May 27
| +0.09 / +0.16%|
The 21 analysts offering 12-month price forecasts for Merck have a median target of 62.00, with a high estimate of 80.04 and a low estimate of 54.00. The median estimate represents a +9.77% increase from the last price of 56.48.
The current consensus among 24 polled investment analysts is to Hold stock in Merck. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.